Cochrane Abstracts
Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Zidovudine (AZT) Versus AZT Plus Didanosine (ddI) Versus AZT Plus Zalcitabine (ddC) in HIV Infected Adults: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432241/all/Zidovudine__AZT__versus_AZT_plus_didanosine__ddI__versus_AZT_plus_zalcitabine__ddC__in_HIV_infected_adults:_Cochrane_systematic_review.
Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432241/all/Zidovudine__AZT__versus_AZT_plus_didanosine__ddI__versus_AZT_plus_zalcitabine__ddC__in_HIV_infected_adults:_Cochrane_systematic_review. Accessed January 17, 2025.
Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults: Cochrane systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432241/all/Zidovudine__AZT__versus_AZT_plus_didanosine__ddI__versus_AZT_plus_zalcitabine__ddC__in_HIV_infected_adults:_Cochrane_systematic_review
Zidovudine (AZT) Versus AZT Plus Didanosine (ddI) Versus AZT Plus Zalcitabine (ddC) in HIV Infected Adults: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432241/all/Zidovudine__AZT__versus_AZT_plus_didanosine__ddI__versus_AZT_plus_zalcitabine__ddC__in_HIV_infected_adults:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults: Cochrane systematic review
ID - 432241
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432241/all/Zidovudine__AZT__versus_AZT_plus_didanosine__ddI__versus_AZT_plus_zalcitabine__ddC__in_HIV_infected_adults:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
